GL1X · GenesisL1 explorer

Research workbench

Mechanism of molecular recognition. structural aspects of 3,3'-diiodo- L-thyronine binding to human serum transthyretin

Analyse Mechanism of molecular recognition. structural aspects of 3,3'-diiodo… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1THA
Type
protein
Length
234 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
T33
Pockets
1 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1187% helix, 50% strandP02766
BTransthyretinprotein1165% helix, 49% strandP02766

Ligands and binding sites

  • T33 · 3,3'-deiodo-thyroxine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.330.7615empty

Interfaces

1 interface between chains.

  • A–B · 935 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 1THA · Mechanism of molecular recognition. structural aspects of 3,3'-diiodo-L-thyronine binding… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.